ANDA 202684, held by Lotus Pharm Co Ltd. Levonorgestrel.
As of Nov 13, 2026, ANDA 202684 (Levonorgestrel), held by Lotus Pharm Co Ltd, was first approved by FDA on Sep 2, 2016, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 2, 2016 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Levonorgestrel0.75MG ยท tablet;oral | Levonorgestrel | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
